Loading...
XKRX
002630
Market cap34mUSD
Jul 10, Last price  
882.00KRW
1D
2.68%
1Q
59.78%
Jan 2017
-75.66%
Name

Orient Bio Inc

Chart & Performance

D1W1MN
XKRX:002630 chart
P/E
—
P/S
1.76
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.93%
Rev. gr., 5y
-10.57%
Revenues
29.75b
+1.21%
22,451,710,00043,857,141,00042,803,189,00044,736,561,00048,171,311,00052,052,582,02076,980,372,44083,722,281,28093,709,381,140105,049,545,520109,019,002,320121,207,763,26030,373,353,89037,699,312,90052,020,405,17026,276,462,48028,819,028,14028,005,127,32029,397,883,00029,754,399,000
Net income
-4.57b
L-65.39%
526,732,000-4,556,272,000-622,871,000-579,886,0004,066,486,000-10,601,938,550878,817,260-9,550,821,260-1,749,195,210-3,009,261,090-19,126,520,540-13,865,151,000-19,505,949,560-10,880,761,690-15,633,538,12034,198,169,000-12,423,707,81012,871,053,370-13,194,866,000-4,566,923,000
CFO
2.60b
+245.13%
1,517,804,000-5,356,962,000-1,859,896,0009,351,273,0003,114,785,000-7,867,483,2005,094,251,3602,169,073,3601,603,027,680912,429,000-4,652,575,000-1,966,434,150-11,539,791,130-4,671,820,9208,739,490,6502,351,249,0001,159,936,9603,756,538,150752,291,0002,596,419,179

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ORIENT BIO Inc. is a South Korean company active within the biotechnology sector. The firm specializes in providing laboratory animals and a range of equipment tailored for research environments. Established in 1959, the company initially operated as Orient Co., Ltd. before being rebranded as ORIENT BIO Inc. in 2005. Its operations are headquartered in Seongnam, South Korea.
URL
https://www.orientbio.co.kr/
IPO date
Dec 28, 1976
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT